Memorial Sloan-Kettering Cancer Center

Long Island City, New York 11101

2 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Lung Cancer - Non Small Cell Non-Squamous, Lung Cancer - Non Small Cell Squamous, Metastatic Head and Neck Cancer, Metastatic Pancreas Adenocarcinoma, Multiple Myeloma, Myelodysplastic Syndromes, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma

Studies at this site

• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) — Running, not enrolling
• Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer — Withdrawn before enrolling
• A Study of NB003 in Patients With Advanced Malignancies — Completed
• A Study of PF-06873600 in People With Cancer — Stopped early
• Expanded Access Program for Revumenib — NO_LONGER_AVAILABLE
• Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) — Running, not enrolling
• Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma — NO_LONGER_AVAILABLE